FDA Leadership Shift: Commissioner Makary Resigns Amid Pressure

U.S. Food and Drug Commissioner Marty Makary is set to resign, marking a significant change at the federal health department. Deputy Commissioner Kyle Diamantas will lead the agency temporarily. The resignation follows speculation and pressure, with the FDA and White House yet to comment on the situation.

Marty Makary, the U.S. Food and Drug Commissioner, is stepping down from his role on Tuesday, sources familiar with the matter confirm. This departure is the latest in a series of leadership changes at the federal health department.

FDA Deputy Commissioner Kyle Diamantas has been appointed to serve as the acting head of the agency, according to a report by Politico. This decision comes amidst weeks of public speculation and growing pressure on Makary.

As of now, neither the White House nor the FDA has issued any official statements or responses regarding Makary's impending resignation.